Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Akebia Therapeutics to Present at Upcoming Investor Conferences


Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, today announced its executives will participate in the following investor conferences:

Where applicable, a live webcast and replay of Akebia's presentation will be available on the Company's website at www.akebia.com.

About Akebia Therapeutics

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.


These press releases may also interest you

at 01:20
Regulatory News: Verimatrix, (Paris:VMX) (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that ProtectMyApp, an application shielding solution for mobile app developers, was...

at 01:05
«Be the change you want to see in the world,» is a well-worn cliché. However, most of us feel overwhelmed in the face of the climate and environmental challenges. Instead of giving in, Cape Town-based Danielle Laity and her team decided to do...

at 01:05
Dassault Systèmes (Paris:DSY) (Euronext Paris: #13065, DSY.PA) today announced that the company-wide rollout of the 3DEXPERIENCE platform at Ericsson, one of the world's leading providers of information and communication technology, has been started....

at 00:45
CellSafe, a specialist in developing diagnostics located at the Republic of Korea and Dynasty Castle Investments Limited, a Hong Kong based company specializing in the procurement, distribution and delivery of medical supplies, today announced that...

at 00:14
Cardiff Oncology, Inc. , a clinical-stage oncology therapeutics company developing drugs to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorectal cancer, castration-resistant prostate cancer and...

at 00:05
Leading cryptocurrency exchange bitFlyer has announced the launch of cross-border trading on its platform. For the first time, users in Europe will be able to access one of the largest bitcoin markets in Japan, while still using a European-regulated...



News published on 21 november 2019 at 08:05 and distributed by: